此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Timely Nudge About Lab Results to Increase myGeisinger Uptake

2021年5月18日 更新者:Amir Goren、Geisinger Clinic

Nudging myGeisinger Enrollment Using Timely Email Messaging Reminding Patients of Lab Results Available

The purpose of the current study is to test whether sending email communications in a timely manner - when patients have laboratory results available to view on the myGeisinger patient portal - increases enrollment in the portal.

研究概览

详细说明

Online patient portals are convenient tools that improve patient access to healthcare services while often reducing burden to both patients and providers. However, many patients have not enrolled in such portals, including Geisinger's patient portal, known as myGeisinger.

The purpose of the current study is to test whether sending myGeisinger enrollment information in a timely manner - when the benefits of enrolling are most readily available - increases enrollment. Specifically, messages will be timely in terms of lab test results having just been made available online, with the added benefit that patients can view their results prior to receiving them via mail. Unenrolled patients who recently had a laboratory procedure ordered and whose results are now ready for sharing will be informed via email that their lab results are available. At the same time, these patients will be reminded that these results can be viewed online through myGeisinger.

The primary outcome measure of interest, myGeisinger enrollment rates, will be compared between the emailed population and a control group that similarly has lab results available but will not be contacted. In addition, two different versions of the email communication will be tested. One will highlight that the patient will have to go through a sign-up process before viewing test results (in the service of transparency). The other will provide a presumed direct link to view those results, via a button that potentially serves as a pre-commitment step to undergo the registration process ("foot in the door" effect). Secondary analyses will assess differences in enrollment rates as well as unsubscribe rates between the email versions. Exploratory analyses will further examine differences in the rates at which patients opened and clicked on enrollment links within the two emails. Statistical analyses will employ generalized linear models with a binary distribution and log-link function.

研究类型

介入性

注册 (实际的)

5012

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Pennsylvania
      • Danville、Pennsylvania、美国、17822
        • Geisinger

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Geisinger patient for whom a lab was ordered within 30 days prior to email date
  • Patient's lab test result released day before email date

Exclusion Criteria:

  • Patient already enrolled in myGeisinger
  • Patient has already declined myGeisinger

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:卫生服务研究
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
无干预:Control
Patients do not receive an email
实验性的:Timely nudge - view results
Patients are emailed about myGeisinger when they have a lab result ready to view. The email includes a "View My Lab Results" button, which encourages them to click as a pre-commitment step that then brings them to the myGeisinger sign-up page.
Email
Email
实验性的:Timely nudge - get started
Patients are emailed about myGeisinger when they have a lab result ready to view. The email includes a "Get Started With myGeisinger" button that is transparent about the next step in the process, before the patient can view test results.
Email
Email

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
大体时间:1 week post-intervention
Patient enrolled in myGeisinger (yes / no)
1 week post-intervention

次要结果测量

结果测量
措施说明
大体时间
Enrollment - Email Including a "Get Started" Button vs. a "View Results" Button
大体时间:1 week post-intervention
Patient enrolled in myGeisinger (yes / no)
1 week post-intervention
Email Opened - Email Including a "Get Started" Button vs. a "View Results" Button
大体时间:1 week post-intervention
Email was opened (yes / no)
1 week post-intervention
Link Clicked - Email Including a "Get Started" Button vs. a "View Results" Button
大体时间:1 week post-intervention
Link / button to start the enrollment process was clicked (yes / no)
1 week post-intervention
Unsubscribed - Email Including a "Get Started" Button vs. a "View Results" Button
大体时间:1 month post-intervention
Patient unsubscribed from these email communications (yes / no)
1 month post-intervention
Enrollment - Timely Email (Combined Email Arms) vs. no Intervention
大体时间:1 month post-intervention
Patient enrolled in myGeisinger (yes / no)
1 month post-intervention

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2020年5月18日

初级完成 (实际的)

2020年6月8日

研究完成 (实际的)

2020年7月1日

研究注册日期

首次提交

2020年4月1日

首先提交符合 QC 标准的

2020年4月1日

首次发布 (实际的)

2020年4月3日

研究记录更新

最后更新发布 (实际的)

2021年6月11日

上次提交的符合 QC 标准的更新

2021年5月18日

最后验证

2021年5月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2020-0316

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

IPD 计划说明

Data with no personally identifiable information will be made available to other researchers on the Open Science Framework for transparency. This will include the essential data and code needed to replicate the analysis that yielded reported findings.

IPD 共享时间框架

The data will become available after publication of study results in a scientific journal and will be available as long as the Open Science Framework hosts the data.

IPD 共享访问标准

The data on the Open Science Framework will be open to anyone requesting that information.

IPD 共享支持信息类型

  • 分析代码

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

健康行为的临床试验

3
订阅